This is a demo store. No orders will be fulfilled.

Recombinant Human LILRB1/CD85j/ILT2 Protein

  • 表达系统: HEK293
  • Accession #: Q8NHL6-1
  • 蛋白标签: C-His
  • 生物活性: When Recombinant Human LILRB1/CD85j/ILT2 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with a typical ED50 of 0.02-0.2 μg/mL.
  • 内毒素水平: <0.1 EU/μg
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
rp148284-10μg
10μg 现货 Stock Image
rp148284-50μg
50μg 现货 Stock Image
rp148284-100μg
100μg 现货 Stock Image
rp148284-1mg
1mg 期货 Stock Image

基本描述

产品名称 Recombinant Human LILRB1/CD85j/ILT2 Protein
别名 重组人LILRB1/CD85j/ILT2蛋白 | 重组人白细胞免疫球蛋白样受体亚家族B成员1蛋白 | 重组人 LILRB1/CD85j/ILT2 蛋白
英文别名 Leukocyte Immunoglobulin-like Receptor, Subfamily A (with TM domain), Member 1 | CD85 antigen-like family member J | CD85j antigen | CD85j | Ig-like transcript 2 | ILT2 | ILT-2 | FLJ37515 | Immunoglobulin-like transcript 2 | leukocyte Ig-like receptor-1 |
规格或纯度 ActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, ≥95%(SDS-PAGE)
产品介绍


Purity
≥95% SDS-PAGE.
Endotoxin level
<0.1 EU/µg
Function
Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response. Engagement of LILRB1 present on natural killer cells or T-cells by class I MHC molecules protects the target cells from lysis. Interaction with HLA-B or HLA-E leads to inhibition of the signal triggered by FCER1A and inhibits serotonin release. Inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

生物活性 When Recombinant Human LILRB1/CD85j/ILT2 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with a typical ED50 of 0.02-0.2 μg/mL.
内毒素水平 <0.1 EU/μg
表达系统 HEK293
种属 人(Human)
氨基酸 24-458 aa
序列 GHLPKPTLWAEPGSVITQGSPVTLRCQGGQETQEYRLYREKKTALWITRIPQELVKKGQFPIPSITWEHAGRYRCYYGSDTAGRSESSDPLELVVTGAYIKPTLSAQPSPVVNSGGNVILQCDSQVAFDGFSLCKEGEDEHPQCLNSQPHARGSSRAIFSVGPVSPSRRWWYRCYAYDSNSPYEWSLPSDLLELLVLGVSKKPSLSVQPGPIVAPEETLTLQCGSDAGYNRFVLYKDGERDFLQLAGAQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSEWSAPSDPLDILIAGQFYDRVSLSVQPGPTVASGENVTLLCQSQGWMQTFLLTKEGAADDPWRLRSTYQSQKYQAEFPMGPVTSAHAGTYRCYGSQSSKPYLLTHPSDPLELVVSGPSGGPSSPTTGPTSTSGPEDQPLTPTGSDPQSGLGRHHHHHHH
纯度 ≥95% (SDS-PAGE)
蛋白标签 C-His
无载体 Yes
无动物源 Yes
Accession # Q8NHL6-1
来源 重组表达
预测分子量 48 kDa
SDS-PAGE 60.0 - 80.0 kDa, under reducing conditions; 60.0 - 80.0 kDa, under non-reducing conditions.

储存与运输

物理形态 冻干(Lyophilized)
储存缓冲液 Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH7.4.
复溶 Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存温度 -20°C储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -20~-80℃ 下可保存 1 年以上。收货后建议分装。避免冷冻/解冻循环。
分子类型 蛋白质

图片

Recombinant Human LILRB1/CD85j/ILT2 Protein (rp148284) - Protein Bioactivity
When Recombinant Human LILRB1/CD85j/ILT2 Protein (rp148284) is coated at 4.0 µg/mL, Biotinylated Recombinant Human Angiopoietin-like 7/ANGPTL7 Protein (rp142833) binds with the ED ₅₀ of 2.0 μg/mL.

Recombinant Human LILRB1/CD85j/ILT2 Protein (rp148284) - SDS-PAGE
3 μg/lane of Recombinant Human LILRB1/CD85j/ILT2 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 60.0 - 80.0 kDa.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ24F0607354 分析证书 rp148284
ZJ24F0607352 分析证书 rp148284
ZJ24F0607353 分析证书 rp148284

溶液计算器